INTRAOCULAR PRESSURE-LOWERING AGENT COMPRISING COMPOUND HAVING HISTONE DEACETYLASE INHIBITORY EFFECT AS ACTIVE INGREDIENT

The object is to find a novel pharmacological activity of a compound capa ble of inhibiting an HDAC. The compound capable of inhibiting a histone deac etylase has an excellent ability of changing the cytomorphology of a trabecu lara cell and/or an excellent ocular hypotensive activity, and is theref...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WATANABE, KATSUHIKO, KIRIHARA, TOMOKO, SHIMAZAKI, ATSUSHI, TAJIMA, HISASHI, FUJISAWA, KOUSHI, YONEDA, SHINJI, FUJIKAWA, JUNKO
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The object is to find a novel pharmacological activity of a compound capa ble of inhibiting an HDAC. The compound capable of inhibiting a histone deac etylase has an excellent ability of changing the cytomorphology of a trabecu lara cell and/or an excellent ocular hypotensive activity, and is therefore useful as a prophylactic and/or therapeutic agent for a disease associated w ith aqueous humor circulation and/or ocular tension, particularly a prophyla ctic and/or therapeutic agent for glaucoma, ocular hypertension or the like.